SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-20-052943
Filing Date
2020-11-10
Accepted
2020-11-10 15:59:41
Documents
14
Period of Report
2020-11-10
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K cris-8k_20201110.htm   iXBRL 8-K 38586
2 EX-99.1 d947249dex991.htm EX-99.1 146649
3 GRAPHIC d947249dlogo.jpg GRAPHIC 18124
  Complete submission text file 0001564590-20-052943.txt   352601

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA cris-20201110.xsd EX-101.SCH 5764
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE cris-20201110_lab.xml EX-101.LAB 19472
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cris-20201110_pre.xml EX-101.PRE 11621
7 EXTRACTED XBRL INSTANCE DOCUMENT cris-8k_20201110_htm.xml XML 3555
Mailing Address 128 SPRING STREET BUILDING C, SUITE 500 LEXINGTON MA 02421
Business Address 128 SPRING STREET BUILDING C, SUITE 500 LEXINGTON MA 02421 617-503-6500
CURIS INC (Filer) CIK: 0001108205 (see all company filings)

IRS No.: 043505116 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-30347 | Film No.: 201301024
SIC: 2836 Biological Products, (No Diagnostic Substances)